Nurix Therapeutics Stock Target Price and Analyst Consensus

NRIX
 Stock
  

USD 13.11  0.08  0.61%   

The current analyst and expert consensus on Nurix Therapeutics is Buy, with 5 strong buy opinions. The current projected Nurix Therapeutics target price consensus is 48.0 with 6 analyst opinions. The most common way Nurix Therapeutics analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview Nurix Therapeutics executives and customers to further validate their buy or sell advice. Note, the total number of analysts currently providing their opinion is not significant to determine adequate consensus on Nurix Therapeutics. We strongly encourage you to use your own analysis of Nurix Therapeutics to validate this buy or sell advice. Nurix Therapeutics buy-or-sell recommendation module provides average expert sentiment on the projected Nurix Therapeutics target price to derive its highest and lowest estimates based on projected price volatility of 6.603. Additionally, see Macroaxis Advice on Nurix Therapeutics to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.
  

Nurix Therapeutics Target Price Consensus

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Nurix target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts performance other than comparing it to the past results via a very sophisticated attribution analysis. Nurix target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
Number of Opinions6
Lowered Outlook0
Raized Outlook0
Buy
Most Nurix analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Nurix stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Nurix Therapeutics, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice   Exposure   Valuation

Nurix Therapeutics Target Price Projection

Nurix Therapeutics' current and average target prices are 13.11 and 48.00, respectively. The current price of Nurix Therapeutics is the price at which Nurix Therapeutics is currently trading. On the other hand, Nurix Therapeutics' target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.

Current Price

Nurix Therapeutics Market Quote on 4th of October 2022

Low Price12.81Odds
High Price13.47Odds

13.11

Target Price

Analyst Consensus On Nurix Therapeutics Target Price

Low Estimate42.0Odds
High Estimate60.0Odds
Number of Analysts6
Standard Deviation6.603

48.0

Note that most analysts generally publish their price targets in research reports on specific companies, along with recommendations for the company's stock.Although price targets are often quoted in the financial news media, there could be a delay between the publication of the latest analyst outlook on Nurix Therapeutics and the information provided on this page.

Nurix Therapeutics Analyst Ratings

Nurix Therapeutics' analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about Nurix Therapeutics stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of Nurix Therapeutics' financials, market performance, and future outlook by experienced professionals. Nurix Therapeutics' historical ratings below, therefore, can serve as a valuable tool for investors.

Analyst Consensus Breakdown

Average Consensus Estimates

About Nurix Therapeutics Target Price Projections

Nurix Therapeutics's target price is an analyst's projection of its future price. Price targets can be assigned to all types of securities, from complex investment products to stocks such as Nurix Therapeutics and even bonds. If the target price is unavailable, it is most likely because there were not enough analyst opinions to come up with a consensus estimate. When setting a price target estimate, an analyst is trying to determine what the Stock is worth and where the price will be in a year from now. Generally, the target price of Nurix depends on its intrinsic valuation, beta (i.e., risk over market), and overall volatility. Most analysts publish their price targets in research reports on specific companies, along with their buy, hold, or sell recommendations. Stock price targets are often quoted in the financial news media. Macroaxis uses multiple feeds to provide overall target price projection for Nurix Therapeutics including analysis of its current option contracts.
Nurix Therapeutics' latest option contracts expiring on 2022-10-21 are carrying combined implied volatility of 5.68 with a put-to-call open interest ratio of 0.07 over 22 outstanding agreements suggesting investors are buying way more calls than puts on contracts expiring on 2022-10-21. The current put volume is at 11, with calls trading at the volume of 101. This yields a 0.11 put-to-call volume ratio. The Nurix Therapeutics option chain provides detailed quote and price information for the current Nurix Therapeutics option contracts. It shows all of Nurix Therapeutics' listed puts, calls, expiration dates, strike prices, and other pricing information.
Nurix Therapeutics' stock options are financial instruments that give investors the right to buy or sell shares of Nurix Therapeutics common stock at a specified price for a given time period. Generally speaking, an option to purchase or sell Nurix stock makes it part of the underlying stock when the option's price is tied to the movement of the underlying stock. If Nurix Therapeutics' stock price goes up or down, the stock options follow.
Additionally, see Macroaxis Advice on Nurix Therapeutics to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.

Nurix Current Options Market Mood

Nurix Therapeutics' open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Nurix Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.

Put-to-Call Open Interest

Put-to-Call Volume

Most options investors, including buyers and sellers of Nurix Therapeutics' calls and puts, are not very successful. It is estimated that an average options trader loses somewhere between 80% to 90% of the time. Nurix Therapeutics' option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction. Using current Nurix Therapeutics' option volume and open interest to make an investment decision is considered a contrarian-sentiment measure that can be utilized in many timing strategies in both derivative and spot marketplace.

Additional Nurix Therapeutics Value Projection Modules

Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Nurix Therapeutics is a key component of Nurix Therapeutics valuation and have some predictive power on the future returns of a Nurix Therapeutics.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Nurix Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Nurix Therapeutics in the context of predictive analytics.
Hype
Prediction
LowEstimated ValueHigh
8.1113.1318.15
Details
Intrinsic
Valuation
LowReal ValueHigh
11.8022.2027.22
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Nurix Therapeutics. Your research has to be compared to or analyzed against Nurix Therapeutics' peers to derive any actionable benefits. When done correctly, Nurix Therapeutics' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Nurix Therapeutics.

Additional Nurix Therapeutics Value Projection Modules

Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Nurix Therapeutics is a key component of Nurix Therapeutics valuation and have some predictive power on the future returns of a Nurix Therapeutics.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Nurix Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Nurix Therapeutics in the context of predictive analytics.
Hype
Prediction
LowEstimated ValueHigh
8.1113.1318.15
Details
Intrinsic
Valuation
LowReal ValueHigh
11.8022.2027.22
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Nurix Therapeutics. Your research has to be compared to or analyzed against Nurix Therapeutics' peers to derive any actionable benefits. When done correctly, Nurix Therapeutics' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Nurix Therapeutics.

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
Management
Invested over 90 shares
Macroaxis Index
Invested over 90 shares
Additionally, see Macroaxis Advice on Nurix Therapeutics to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. You can also try Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.

Complementary Tools for analysis

When running Nurix Therapeutics price analysis, check to measure Nurix Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nurix Therapeutics is operating at the current time. Most of Nurix Therapeutics' value examination focuses on studying past and present price action to predict the probability of Nurix Therapeutics' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Nurix Therapeutics' price. Additionally, you may evaluate how the addition of Nurix Therapeutics to your portfolios can decrease your overall portfolio volatility.
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Go
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Go
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Go
ETF Directory
Find actively traded Exchange Traded Funds (ETF) from around the world
Go
Focused Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Go
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Go
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Go
The data published in Nurix Therapeutics' official financial statements usually reflect Nurix Therapeutics' business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Nurix Therapeutics. For example, before you start analyzing numbers published by Nurix accountants, it's critical to develop an understanding of what Nurix Therapeutics' liquidity, profitability, and earnings quality are in the context of the Healthcare space in which it operates.
Please note, the presentation of Nurix Therapeutics' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Nurix Therapeutics' management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Nurix Therapeutics' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Nurix Therapeutics. Please utilize our Beneish M Score to check the likelihood of Nurix Therapeutics' management to manipulate its earnings.